GFACX
Price
$71.52
Change
+$0.63 (+0.89%)
Updated
Aug 6 closing price
Net Assets
322.41B
ITRGX
Price
$68.94
Change
+$0.90 (+1.32%)
Updated
Aug 6 closing price
Net Assets
1.41B
Interact to see
Advertisement

GFACX vs ITRGX

Header iconGFACX vs ITRGX Comparison
Open Charts GFACX vs ITRGXBanner chart's image
American Funds Growth Fund of Amer C
Price$71.52
Change+$0.63 (+0.89%)
VolumeN/A
Net Assets322.41B
VY® T. Rowe Price Growth Equity S2
Price$68.94
Change+$0.90 (+1.32%)
VolumeN/A
Net Assets1.41B
GFACX vs ITRGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. ITRGX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and ITRGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 322B vs. ITRGX (1.41B). GFACX (0.00) and ITRGX (0.00) have matching dividends . GFACX was incepted earlier than ITRGX: GFACX (24 years) vs ITRGX (16 years). GFACX (1.36) is less costly to investors than ITRGX (1.19). ITRGX is a more actively managed with annual turnover of: 39.00 vs. GFACX (25.00). ITRGX has a lower initial minimum investment than GFACX: ITRGX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 18.41 vs. ITRGX (-3.56). GFACX return over 5 years is better than : 33.13 vs. ITRGX (-18.47).
GFACXITRGXGFACX / ITRGX
Total Expense Ratio1.361.11123%
Annual Report Gross Expense Ratio1.361.19114%
Fund Existence24 years16 years-
Gain YTD12.171-17.327-70%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets322B1.41B22,869%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.41-3.56-517%
Returns for 3 years39.6310.11392%
Returns for 5 years33.13-18.47-179%
Returns for 10 years67.85-17.87-380%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.260.14
+6.60%
Spero Therapeutics
UXIN3.830.11
+2.96%
Uxin Limited
CCRN13.100.26
+2.02%
Cross Country Healthcare
GBDC14.78-0.01
-0.07%
Golub Capital BDC
CRBG34.23-0.07
-0.20%
Corebridge Financial